muscle loss with semaglutide Is Causing YOUR Loss? Bodyfat loss with some muscle
Description
It reduces hunger by acting on the brains appetite centers
Beyond T2D and obesity, semaglutide was also applied for other indications such as cardiovascular disease, fatty liver, chronic kidney disease, all of which have progressed to Phase 3, expanding the influence of GLP-1RAs into more medical fields
In obesity clinical trials, patients achieved approximately 15-21% weight loss over 72 weeks, with somewhat smaller weight reductions typically seen in diabetes trials
We can tailor steps to your goals and medical history
